Hemolytic anemia provoked by recombinant alpha-interferon
- 1 December 1995
- journal article
- case report
- Published by Springer Nature in The Esophagus
- Vol. 30 (6) , 795-797
- https://doi.org/10.1007/bf02349651
Abstract
A 30-year-old female with chronic hepatitis C treated with recombinant alpha-interferon developed serious hemolytic anemia after receiving 10 million units a day for 4 weeks. The results of Coombs' tests were negative before and after interferon therapy. The hemolytic anemia gradually improved after the with-drawal of recombinant alpha-interferon and the administration of methyl-prednisolone. The clinical course suggested that the recombinant alpha-interferon had provoked the hemolytic anemia.Keywords
This publication has 12 references indexed in Scilit:
- Autoimmunity after Alpha-Interferon Therapy for Malignant Carcinoid TumorsAnnals of Internal Medicine, 1991
- Side Effects of Alpha InterferonSeminars in Liver Disease, 1989
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986
- Alpha-Interferon and Immune Hemolytic AnemiaAnnals of Internal Medicine, 1986
- Interferon-activated genesTrends in Biochemical Sciences, 1986
- Effects of interferon-α on the expression of a lupus idiotype in normal humansClinical Immunology and Immunopathology, 1986
- INTERFERON-INDUCED PAROTITIS AND EPIDIDYMITISThe Lancet, 1985
- AUTOIMMUNE THYROID DISEASE IN INTERFERON-TREATED PATIENTSThe Lancet, 1985
- PRIMARY HYPOTHYROIDISM ASSOCIATED WITH INTERFERON THERAPY OF BREAST CANCERThe Lancet, 1985
- Virus interference. I. The interferonProceedings of the Royal Society of London. B. Biological Sciences, 1957